Stock UniverseDerived research view · source repositories remain read-only

West Pharmaceutical Services, Inc. (WST)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Instruments & Supplies
Score Band
High
Selection Score
40.01
Global Rank
406
Market Cap
18.32B
Latest Close
314.50
RS Composite
12.10% · G#666

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
0.62%
3M
28.01%
6M
10.80%
1Y
49.24%
3Y
-5.22%
5Y
-8.32%
10Y
334.82%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 442.86K · 30-day average: 813.92K · Max drawdown over stored range: -59.29%

Research Snapshot

Relative Strength vs SPX

RS Composite12.10%
20D RS-2.97%
60D RS23.13%
120D RS8.59%
Global RS Rank666 · 80.15% percentile
Qualified+ RS Rank258 · 79.49% percentile
Group ScopeQualified+
Primary RS Rank19 · 86.62% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank38 / 246
Primary Percentile84.96
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-04-233.22B1.17B655.00M542.70M7.481.15B475.10M676.10M73M36.28%20.34%16.85%35.74%20.99%521.40M202.80M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$7.4842.0x$44.407.1x$9.3233.7x$15.8719.8x

Shares Diluted: 73M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue2831.62886.92949.82893.23074.1
Revenue Growth (YoY)31.892%1.953%2.179%-1.919%6.253%
Gross Profit1177.71136.21130998.51104
Operating Income768.6763.8706.2593.6612.7
Free Cash Flow330.6439.4414.5276.4468.9
Free Cash Flow Per Share4.3335.7975.5053.756.45
EPS (Diluted) GAAP8.677.737.886.696.79
EPS Growth89.716%-10.842%1.94%-15.102%1.495%
EPS Non-GAAP
Gross Margin41.591%39.357%38.308%34.512%35.913%
Operating Margin27.144%26.457%23.941%20.517%19.931%
Profit Margin23.372%20.295%20.117%17.03%16.06%
Free Cash Flow Margin11.675%15.22%14.052%9.553%15.253%
Shares Outstanding (Diluted)76.375.875.373.772.7
Shares Change (YoY)0.66%-0.655%-0.66%-2.125%-1.357%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-04-23844.90M35.08%177.10M20.96%138.80M16.43%1.9272.40M521.40M202.80Mprocessed
2025 Q42026-02-17805.00M37.75%156.60M19.45%132.10M16.41%1.8272.70M791.30M202.80Mprocessed
2025 Q32025-10-23804.60M36.58%167.60M20.83%140.00M17.40%1.9272.60M628.50M202.70Mprocessed
2025 Q22025-07-24766.50M35.73%153.70M20.05%131.80M17.20%1.8272.50M509.70M202.60Mprocessed
2025 Q12025-04-24698.00M33.22%107.00M15.33%89.80M12.87%1.2373.00M404.20M202.60Mprocessed
2024 Q42025-02-18748.80M36.54%159.60M21.31%130.10M17.37%1.7773.40M484.60M202.60Mprocessed
2024 Q32024-10-24746.90M35.44%161.30M21.60%136.00M18.21%1.8573.40M490.90M202.60Mprocessed
2024 Q22024-07-25702.10M32.76%126.20M17.97%111.30M15.85%1.5173.70M446.20M72.90Mprocessed
2024 Q12024-04-25695.40M33.10%122.80M17.66%115.30M16.58%1.5574.30M601.80M72.80Mprocessed
2023 Q42024-02-20732.00M38.01%160.90M21.98%137.00M18.72%1.8374.70M853.90M72.80Mprocessed
2023 Q32023-10-26747.40M38.57%177.30M23.72%161.30M21.58%2.1475.30M898.60M152.10Mprocessed
2023 Q22023-07-27753.80M38.66%182.50M24.21%155.10M20.58%2.0675.40M796.30M205.60Mprocessed
2023 Q12023-04-27716.60M37.86%155.30M21.67%140.00M19.54%1.8575.70M886.30M206.10Mprocessed
2022 Q42023-02-21708.70M36.98%129.70M18.30%103.00M14.53%1.3675.50M894.30M206.70Mprocessed
2022 Q32022-10-27686.90M39.02%186.20M27.11%120.60M17.56%1.5975.70M729.00M207.20Mprocessed
2022 Q22022-07-28771.30M41.68%228.40M29.61%188.50M24.44%2.4875.80M718.50M207.80Mprocessed
2022 Q12022-04-28720.00M39.53%189.70M26.35%173.80M24.14%2.2976.00M667.70M208.30Mprocessed
2021 Q42022-02-22730.80M41.13%184.00M25.18%147.70M20.21%1.9077.80M762.60M208.80Mprocessed
2021 Q32021-10-28706.50M40.79%181.40M25.68%175.60M24.85%2.3176.00M688.00M209.90Mprocessed
2021 Q22021-07-30723.60M43.55%211.30M29.20%187.30M25.88%2.4775.70M576.20M251.80Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.